Index by author

January 01, 2021; Volume 88,Issue 1

  1. Sooriakumaran, Prasanna

    1. Prostate cancer screening and the role of PSA: A UK perspective
      Prasanna Sooriakumaran, MD, PhD, FRCSUrol, FEBU
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 14-16; DOI: https://doi.org/10.3949/ccjm.88a.20164

      We advocate PSA screening for all middle-aged men, especially if they have risk factors.

  2. Stewart, Jonathan

    1. A patient with breast cancer and a rash on her hands and feet
      Jonathan Stewart, BS, Grace U. Salacup, MD and Kevin Bryan Uy Lo, MD
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 22-23; DOI: https://doi.org/10.3949/ccjm.88a.20020

      She had completed her third cycle of chemotherapy 3 days earlier.

  3. Taliercio, Jonathan J.

    1. SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
      Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

      Randomized controlled trials of these new agents had positive outcomes.

  4. Taylor, James S.

    1. Cleveland Clinic Journal of Medicine: Evolution and a look ahead
      James S. Taylor, MD, FAAD
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 11-13; DOI: https://doi.org/10.3949/ccjm.88a.20187

      Cleveland Clinic is 100 years old and has had a medical journal for 90 of those years.

  5. Thomas, George

    1. SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
      Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

      Randomized controlled trials of these new agents had positive outcomes.

  6. Tsushima, Yumiko

    1. The role of SGLT-2 inhibitors in managing type 2 diabetes
      Yumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACE
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088

      These drugs improve glycemic control and offer cardiovascular and metabolic benefits.

  7. Vachharajani, Tushar J.

    1. SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
      Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd
      Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

      Randomized controlled trials of these new agents had positive outcomes.

« Previous (Pages : 1 2 3 ... 3)next »
Back to top

In this issue